Protalix BioTherapeutics
PLX
#8476
Rank
NZ$0.28 B
Marketcap
$3.81
Share price
-3.13%
Change (1 day)
54.37%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -NZ$12.83 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$45.66 Million. In 2023 the company made an earning of NZ$20.61 Million, an increase over its 2022 earnings that were of -NZ$20.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$12.83 Million-162.19%
2023 NZ$20.61 M-199.05%
2022 -NZ$20.82 Million-40.38%
2021 -NZ$34.92 Million-732.31%
2020 NZ$5.52 M-130.53%
2019 -NZ$18.09 Million189.85%
2018 -NZ$6.24 Million-95.29%
2017 -NZ$0.14 Billion308.12%
2016 -NZ$32.47 Million-32.37%
2015 -NZ$48.01 Million10.11%
2014 -NZ$43.6 Million-7.59%
2013 -NZ$47.18 Million
2011 -NZ$54.64 Million-19.39%
2010 -NZ$67.78 Million20.87%
2009 -NZ$56.08 Million32.26%
2008 -NZ$42.4 Million-5.46%
2007 -NZ$44.85 Million
2004 -NZ$0.3 Million12.35%
2003 -NZ$0.26 Million-11.1%
2002 -NZ$0.3 Million-57.03%
2001 -NZ$0.68 Million1.03%
2000 -NZ$0.67 Million-53.22%
1999 -NZ$1.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$50.44 Million 270.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.90 B-6,716.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.17 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.5 Billion 3,534.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel